1Moch H, Humphrey P, Ulbright T, et al. WHO classification of tumours of the urinary system and male genital organ [ M 1. Lyon : IARC Press, 2016.
2Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia[ J ]. Am J Surg Pathol, 2013,37 ( 10 ) : 1469-1489. DOI: 10. 1097/PAS. 0b013e318299f2dl.
3Yakirevich E, Magi-Galluzzi C, Grada Z, et al. Cadherin 17 is a sensitive and specific marker for metanephric adenoma[ J]. Am J Surg Pathol, 2015, 39 (4) : 479-486. DOI: 10. 1097/PAS.
4Rao Q, Xia QY, Wang ZY, et al. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours [ J ]. Histopathology, 2015,67 ( 1 ) : 121-129. DOI:10. llll/his. 12632.
5Rao Q, Cheng L, Xia QY, et al. Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): a clinicopathological study emphasizing extrarenal PEComas[J]. Histopathology, 2013,62(4) :642-650. DOI: 10. 1111/his. 12059.
6Rao Q, Shen Q, Xia QY, et al. PSF/SFPQ is a very common gene fusion partner in TFF3 rearrangement-associated perivaseular epithelioid cell tumors (PEComas) and melanotie Xpl 1 translocationrenal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity [ J ]. Am J Surg Pathol, 2015, 39 (9): 1181-1196. DOI: I0. 1097/PAS. 502.
7Rao Q, Liu B, Cheng L, et al. Renal cell carcinomas with t (6; 11 )( p21 ;q12): a clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and uhrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization [J]. Am J Surg Pathol, 2012,36(9):1327-1338. DOI: 10. 1097/PAS. 0bO13e31825aafb5.
8Rao Q, Williamson SR, Zhang S, et al. TFE3 break-apart FISH has a higher sensitivity for Xpl 1.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum[J]. Am J Surg Pathol, 2013,37 (6) : 804-815. DOI: 10. 1097/PAS. ObO13e31827e17eb.
9Pflueger D, Sboner A, Storz M, et al. Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing [ J ]. Neoplasia, 2013,15 ( 11 ) : 1231-1240.
10Cancer Genome Atlas Research Network; Linehan WM, Spellman PT, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma[J]. N Engl J Med, 2016, 374 (2) : 135- 145. DOI: 10. 1056/NEJMoa1505917.
